Clinical Trial

The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind, placebo-controlled phase I bridging study to evaluate the PK, safety and tolerability of SR750 (formulation F1) in Chinese healthy subjects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-10; most recent amendment 2025-12-25.
Status change: Not Yet Recruiting → Completed 2025-12-25
Trial Details
NCT Number NCT06932536
Lead Sponsor Shanghai SIMR Biotechnology Co., Ltd.
Conditions Healthy
Enrollment 40 participants
Start Date 2025-04-28
Primary Completion 2025-07-07 (estimated)
Study Completion 2025-07-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-31